Skip to main content
OpenTrials

Clinical trial condition

Stage IIIC Ovarian Cancer

Explore clinical trials studying Stage IIIC Ovarian Cancer. Study availability and eligibility vary by location and protocol.

18 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IIIC Ovarian Cancer trial results

Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

NCT01080521

Conditions
Adnexal Diseases, Brenner Tumor, Cognitive Side Effects of Cancer Therapy, +79 more
Locations
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Roy and Patricia Disney Family Cancer Center Burbank, California, United States
View all 182 locations
View Trial Details
Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

NCT00857545

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +38 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 46 locations
View Trial Details
Completed

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

NCT02311907

Conditions
Adnexal Diseases, Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, +37 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Northbay Cancer Center Fairfield, California, United States
View all 390 locations
View Trial Details
Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

NCT00897442

Conditions
Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
Locations
  • Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
  • Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
View all 187 locations
View Trial Details

Related conditions